Capto AS, the wholly owned subsidiary of SensoNor asa, has today entered into an agreement with a major medical equipment company for the exclusive supply of Pressure Transducers used to measure invasive blood pressure and foetal pressure.
According to Hugin, the expected value of the agreement is approximately NOK 20 million over three years with deliveries commencing immediately.
Capto's physiological pressure transducer has been on the market for several years. This agreement is however the largest single contract that has been signed for this product.
The U.S. based company is a world-leading supplier of diagnostic medical equipment and represents an important reference for Capto within the global medical market.
The U.S. company, listed on the New York Stock Exchange, is a global, diversified technology company focusing on high-growth markets in the communications, electronics, life sciences and healthcare industries with revenues in year 2000 in excess of 10.00 billion dollars.
Capto AS is a wholly owned subsidiary of SensoNor asa. Capto manufactures and markets sensors for applications within the medical and aerospace industries